Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat

Neurology

Volumn 52, Issue 2, 1999, Pages 273-279

  Zhang, Rui Lan ^a   Zhang, Zheng Gang ^a   Chopp, Michael ^a,b,c  

^a HENRY FORD HEALTH SCIENCES CENTER   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CD18 ANTIGEN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY WT 3; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; DRUG EFFICACY; FIBRINOLYTIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

EID: 0345251951     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.2.273     Document Type: Article

References (33)

1. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997;350:607-614.
3. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study. JAMA 1995;274:1017-1025.
4. Lyden PD, Zivin JA. Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc Brain Metab Rev 1993;5:1-16.
5. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
6. Zivin JA. Factors determining the therapeutic window for stroke. Neurology 1998;50:599-603.
7. Zhang RL, Chopp M, Jiang N, Tang WX, Prostak J, Manning AM. Anti-ICAM-1 antibody reduces ischemic cell damage after transient but not permanent MCA occlusion in the Wistar rat. Stroke 1995;26:1438-1443.
8. Jiang N, Moyle M, Soule HR, Rote WE, Chopp M. Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann Neurol 1995;38:935-942.
9. Zhang RL, Chopp M, Zhang ZG, et al. E-selectin in focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab 1996;16:1126-1136.
10. Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR. Post ischemic administration of an anti-MAC-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Stroke 1994;25:869-876.
11. Goussev A, Zhang ZG, Anderson DC, Chopp M. P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat. J Neurol Sci 1999 (in press).
12. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.
13. Bowes MP, Rothlein R, Fagan SC, Zivin JA. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 1995;45:815-819.
14. Zhang RL, Chopp M, Zhang ZG, Jiang Q. A rat model of focal embolic cerebral ischemia. Brain Res 1997;766:83-92.
15. Zea Longa Z, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
16. Zhang ZG, Chopp M. Measurement of myeloperoxidase immunoreactive cells in ischemic brain after transient middle cerebral artery occlusion in the rat. Neurosci Res Comm 1997;20: 85-91.
17. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. New York: Academic Press, 1986.
18. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290-293.
19. Yamazaki T, Seko Y, Tamatani T, et al. Expression of intercellular adhesion molecule-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol 1993;143:410-418.
20. Zhang RL, Chopp M, Zhang ZG. Early (1H) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats. J Neurol Sci 1998;160:1-8.
21. Overgaard K, Sereghy T, Boysen G, Pedersen H, Diemer NH. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model. Scand J Clin Lab Invest 1993;53: 383-393.
22. Overgaard K, Sereghy T, Pedersen H, Boysen G. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab 1994;14:472-477.
23. Sakurama T, Kitamura R, Kaneko M. Tissue-type plasmino-gen activator improves neurological functions in a rat model of thromboembolic stroke. Stroke 1994;25:451-456.
24. Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Divine GW, Chopp M. Diffusion, T2, and perfusion weighted NMR imaging of middle cerebral artery embolic stroke and rt-PA intervention in rat. J Cereb Blood Flow Metab 1998;18:758-767.
25. The Enlimomab Acute Stroke Trial Investigators. The Enlimomab Acute Stroke Trial: final results. Cerebrovasc Dis 1997;7(suppl 4):18. Abstract.
26. del Zoppo GJ, Copeland BR, Anderchek K, Hacke W, Koziol JA. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. Stroke 1990;21: 596-601.
27. Anderson JL, Karagounis L, Allen A, Bradford MJ, Menlove RL, Pryor TA. Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol 1991;68:166-170.
28. Saku Y, Choki J, Waki R, et al. Hemorrhagic infarct induced by arterial hypertension in cat brain following middle cerebral artery occlusion. Stroke 1990;21:589-595.
29. Altieri DC. Coagulation assembly on leukocytes in transmembrane signaling and cell adhesion. Blood 1993;81:569-579.
30. Preissner KT, Kanse SM. Protease-receptors in the vasculature: novel aspects of regulation of hemostasis and wound repair. Biomed Prog 1996;9:22-27.
31. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986;17:472-476.
32. Rogers DC, Campbell CA, Stretton JL, Mackay KB. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997;28:2060-2065.
33. Thompson RH, Swanson LW. Organization of inputs to the dorsomedial nucleus of the hypothalamus: a reexamination with fluorogold and PHAL in the rat. Brain Res Rev 1998;27: 89-118.